POT1 clinical risk management is an open question.

IF 3.7 2区生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

European Journal of Human Genetics Pub Date : 2024-08-13 DOI:10.1038/s41431-024-01676-x

Mandy L Ballinger, David M Thomas

引用次数: 0

查看原文本刊更多论文

POT1 临床风险管理是一个悬而未决的问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Human Genetics 生物-生化与分子生物学

CiteScore

9.90

自引率

5.80%

发文量

216

审稿时长

2 months

期刊介绍： The European Journal of Human Genetics is the official journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports and reviews in the rapidly expanding field of human genetics and genomics. It covers molecular, clinical and cytogenetics, interfacing between advanced biomedical research and the clinician, and bridging the great diversity of facilities, resources and viewpoints in the genetics community. Key areas include: -Monogenic and multifactorial disorders -Development and malformation -Hereditary cancer -Medical Genomics -Gene mapping and functional studies -Genotype-phenotype correlations -Genetic variation and genome diversity -Statistical and computational genetics -Bioinformatics -Advances in diagnostics -Therapy and prevention -Animal models -Genetic services -Community genetics